Corrigendum to: “Salicylic acid inhibits Mas-related G protein-coupled receptor X2-mediated mast cell activation and mitigates cutaneous pseudo-allergic reactions” (European Journal of Pharmacology, (2025), 1006, C, (178189), (S0014299925009434), (10.1016/j.ejphar.2025.178189))

The authors regret < that some parts of the title and manuscript contained typographical errors, though these did not affect the scientific content. The corrected places are listed as follows: Title. Current: Salicylic acid inhibits Mas-related G protein-coupled receptor X2-mediated mast cell 2 activation and mitigates cutaneous pseudo-allergic reactions. Corrected: Salicylic acid inhibits Mas-related G protein-coupled receptor X2-mediated mast cell activation and mitigates cutaneous pseudo-allergic reactions. Page 2, Section 2.2 – In vivo murine skin pseudo-allergic reaction model (line 1). Current: C48/80 (30 μg). Corrected: c48/80 (30 μg/ml). Page 2, Section 2.3 – Murine Evans blue dye extravasation model (line 5). Current: c48/80 (30 μg). Corrected: c48/80 (30 μg/ml). Page 4, Fig. 1 legend (line 2). Current: c48/80 (30 μg). Corrected: c48/80 (30 μg/ml). Page 5, Section 3.5 – MRGPRX2 expression was downregulated by SA treatment (line 2). Current: After 1.5h SA incubation. Corrected: After 2.5h SA incubation>. The authors would like to apologise for any inconvenience caused.